Estrace (Postmenopausal Vaginal Atrophy)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Disease Overview 9
3.1 Etiology and Pathophysiology 9
3.1.1 Etiology 9
3.1.2 Pathophysiology 9
3.1.3 Prognosis 10
3.1.4 Quality of Life 10
3.2 Symptoms 10
4 Disease Management 12
4.1 Treatment Overview 12
4.2 Treatment Guidelines 12
4.3 Disease Management 13
5 Competitive Assessment 16
5.1 Overview 16
5.2 Strategic Competitor Assessment 17
6 Estrace (17 beta-estradiol cream) 19
6.1 Overview 19
6.2 Efficacy 20
6.3 Safety 20
6.4 SWOT Analysis 20
6.5 Forecast 21
7 Appendix 22
7.1 Bibliography 22
7.2 Abbreviations 24
7.3 Methodology 26
7.4 Forecasting Methodology 26
7.4.1 Diagnosed postmenopausal atrophy patients 26
7.4.2 Percent Drug-Treated Patients 27
7.4.3 General Pricing Assumptions 27
7.4.4 Individual Drug Assumptions 28
7.4.5 Generic Erosion 28
7.5 Physicians and Specialists Included in This Study 29
7.6 About the Authors 30
7.6.1 Author 30
7.6.2 Epidemiologists 30
7.6.3 Global Director of Epidemiology and Clinical Trials Analysis 31
7.6.4 Director of Oncology, Hematology and Gender Health 31
7.6.5 Global Head of Healthcare 32
7.7 About GlobalData 33
7.8 Disclaimer 33